Click here to load reader
Upload
vijay-mishra
View
12
Download
0
Embed Size (px)
Citation preview
GLOBAL INDUSTRY INSIGHT: Gastrointestinal Over the Control (OTC) Drugs Market Trends, Size,
Share, Development, Growth and Demand Forecast to 2020
Global Gastrointestinal Over the Control (OTC) Drugs Market
Size, Share, Development, Growth and Demand Forecast to 2020
The gastrointestinal over the control drugs market is growing at a significant rate mainly due to increase in patient
population. Strategic alliances are one the major trends that can be seen in the gastrointestinal over the control
drugs market and is supporting the market to grow at a more considerable rate.
Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small
intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are
available without any prescription from the doctor. Over the counter drugs are chosen by regulatory agencies very
carefully so as to ensure their efficacy and safety.
To know more visit: https://www.psmarketresearch.com/market-analysis/gastrointestinal-otc-drugs-market
The gastrointestinal over the control drugs can also be bought without any prescription of doctor. The
gastrointestinal over the control drugs are used for indications such as vomiting, gastro esophageal reflux disease
(GERD), diarrhea, flatulence and constipation. The over the control drugs are not compelled by regulatory
guidelines, but they need to fulfill the drug monograph of a certain country.
On the basis of types of product, the gastrointestinal over the control drugs market can be categorized as
laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti diarrheals, proton pump inhibitors, h2
inhibitors, gastric acid neutralizers, bowel anti-inflammatory and anti emetics. On the basis of indication, the
gastrointestinal over the control drugs market can be categorized as nausea due to motion sickness, heartburn,
flatulence, diarrhea and constipation.
High expenditure on advertisement is one of the major factors restraining the growth of the gastrointestinal over
the control drugs market.
Many countries have applied regulations regarding the gastrointestinal over the control drugs in their countries. In
Canada, an intermediate category exist which states that non prescription stuffs must be kept in a store room,
behind the counter, or on a shelf visible to the pharmacist and the stuffs include weak muscle relaxants, codeine
products, and antihistamines. In the Netherlands, categories of non prescription drugs have been made as
uitsluitend recept, uitsluitend apotheek, uitsluitend apotheek of drogist and algemene verkoop. The uitsluitend
apotheek drug can be on the shelves like any other product. Uitsluitend apotheek of drogist can be sold at
drugstores and it includes only a small selection of drugs such as cough medicine and painkillers. Algemene
verkoop drugs can be sold at gas stations and supermarkets, and it includes drugs with minimal risk to the public
such as cetirizine, paracetamol, loperamide, and 200 mg ibuprofen.
Request for Table of Content: https://www.psmarketresearch.com/market-analysis/Gastrointestinal-
OTC-Drugs-Market/toc-sample
© P&S Market Research. All rights reserved 2
Global Gastrointestinal Over the Control (OTC) Drugs Market
Size, Share, Development, Growth and Demand Forecast to 2020
In the U.S., the Food and Drug Administration regulates the manufacturing and sale of over the control drugs. The
Food and Drug Administration compels that all new drugs should obtain a new drug application (NDA) before it
enters throughway, but the act excuse any drug which is recognized as effective and safe for the requirement.
Some of the over the control drugs approved in the U.S. are anti-microbial, sunscreens, anti fungal products, and
internal and external analgesics. In the U.K., Medicines Regulations 2012 governs the medication. Medication in
the country is categorized as a general sales list, prescription only medication and pharmacy medicines.
Some of the competitors in the gastrointestinal over the control drugs market are Procter & Gamble,
GlaxoSmithKline Pharmaceuticals Limited, Purdue Pharma L.P., Bayer AG, Boehringer Ingelheim GmbH,
Johnson & Johnson Private Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Reckitt Benckiser Group plc,
C.B. Fleet Company, Inc., Perrigo Company plc, Sanofi, OMEGA SA, Abbott Laboratories, and Nestle SA.
Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/healthcare
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports, industry forecasting reports,
business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through
their interaction with leading companies of the concerned domain. We help our clients with B2B market research
and assist them in identifying various windows of opportunity, and framing informed and customized business
expansion strategies in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
© P&S Market Research. All rights reserved 3
Global Gastrointestinal Over the Control (OTC) Drugs Market
Size, Share, Development, Growth and Demand Forecast to 2020
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
© P&S Market Research. All rights reserved 4